Dr Durayd Alzoubaidi

Dr Durayd Alzoubaidi is a Consultant Gastroenterologist and GI Endoscopist at Royal Free Hospital, Hampstead, London, one of the country’s leading teaching hospitals. He has an expertise in Gastroenterology and Endoscopy. He trained at Bart’s and the London school of medicine and completed his Gastroenterology training at Cambridge and London.

He has completed a prestigious 3 year post graduate research degree at University College London (UCL) studying New Innovations in Endoscopic Therapy for Gastrointestinal bleeding and cancer. He has a special interest and expertise in the management and treatment of patients with acid reflux, dyspepsia, abdominal pain and Barrett’s Oesophagus. He also sees patients with diarrhoea, constipation, weight loss, iron deficiency anaemia (IDA,) irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD).

His current research involvements include The International Hemospray Registry analysing novel haemostatic modality in the management of gastrointestinal bleeding. He has personally presented outcomes from this research in several major international conferences and has resulted in multiple publications in peer reviewed medical journals. In addition he is currently working on the development of a risk stratification modality to identify patients at high risk of developing cancer in the upper gastrointestinal tract.

Dr Alzoubaidi is married with two children. Hobbies include cycling, gardening, cooking, photography and sewing.

• Cryoballoon ablation for the treatment of patients with refractory esophageal neoplasia after first line endoscopic eradication therapy.
• Minichromosomal Maintenance Component Complex 5 (MCM5) as a Marker of Barrett’s Esophagus-Related Neoplasia.
• Comparison of two multiband mucosectomy devices for endoscopic resection of Barrett’s related neoplasia.
• Management of non-variceal upper gastrointestinal bleeding.
• Radiofrequency ablation for patients with refractory symptomatic anaemia secondary to gastric antral vascular ectasia.
• Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma
• Artificial intelligence for the real time classification of intrapapillary capillary loop patterns in the endoscopic diagnosis of early oesophageal squamous cell carcinoma
• Virtual chromoendoscopy using optical enhancement improves the detection of Barrett’s esophagus-associated neoplasia.
• Barrett’s Oesophagus and Cancer Risk
• Ascites Management
• HRS Management
• Acute Variceal Haemorrhage Management